SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001679082-22-000009
Filing Date
2022-01-10
Accepted
2022-01-10 09:01:55
Documents
14
Period of Report
2022-01-10
Items
Item 2.02: Results of Operations and Financial Condition

Document Format Files

Seq Description Document Type Size
1 8-K myov-20220110.htm   iXBRL 8-K 46741
2 EX-99.1 a01102022myovantprx010422e.htm EX-99.1 29403
6 myovant16a.jpg GRAPHIC 14626
  Complete submission text file 0001679082-22-000009.txt   248428

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT myov-20220110.xsd EX-101.SCH 1900
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT myov-20220110_lab.xml EX-101.LAB 25955
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT myov-20220110_pre.xml EX-101.PRE 13526
8 EXTRACTED XBRL INSTANCE DOCUMENT myov-20220110_htm.xml XML 11735
Mailing Address SUITE 1, 3RD FLOOR 11-12 ST. JAMES SQUARE LONDON X0 SW1Y 4LB
Business Address SUITE 1, 3RD FLOOR 11-12 ST. JAMES SQUARE LONDON X0 SW1Y 4LB 44 207-400-3351
Myovant Sciences Ltd. (Filer) CIK: 0001679082 (see all company filings)

IRS No.: 000000000 | State of Incorp.: CA | Fiscal Year End: 0331
Type: 8-K | Act: 34 | File No.: 001-37929 | Film No.: 22519961
SIC: 2834 Pharmaceutical Preparations